Genetic testing is transforming depression treatment by tailoring antidepressants to your DNA for better results and fewer ...

The treatment approach involves detecting the TT genotype of rs1042173 in the serotonin transporter gene (SLC6A4) and administering AD04. On December 3, 2024, Adial announced patent number ...

On November 5, 2024, Adial announced the appointment of Vinay Shah as the Company's Chief Financial Officer. Mr. Shah is an accomplished Chief Financial Officer with over 25 years of experience in the ...

In comparison with the vast epidemiological literature on postpartum depression (PPD), relatively few studies have examined the biological aspects of the disorder. However, research into the ...